These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1581233)

  • 21. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.
    Jilma-Stohlawetz P; Quehenberger P; Schima H; Stoiber M; Knöbl P; Steinlechner B; Felli A; Jilma B
    Thromb Res; 2016 Jan; 137():196-201. PubMed ID: 26616301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatment.
    Murakawa M; Okamura T; Tsutsumi K; Tanoguchi S; Kamura T; Shibuya T; Harada M; Niho Y
    Acta Haematol; 1992; 87(1-2):83-7. PubMed ID: 1585777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe von Willebrand's disease: SDS agarose multimer analysis.
    Redaelli R; Pezzetti L; Caimi T; Baudo F; de Cataldo F
    Haemostasis; 1987; 17(5):278-85. PubMed ID: 3499365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
    Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma.
    Tran-Thang C; Mannucci PM; Schneider P; Federici A; Bachmann F
    Br J Haematol; 1985 Oct; 61(2):307-14. PubMed ID: 3929829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collagen-binding of von Willebrand's factor antigen in the classification of von Willebrand's disease.
    Duggan MJ; DiMichele DM; Christian MJ; Fink LM; Hathaway WE
    Am J Clin Pathol; 1987 Jul; 88(1):97-102. PubMed ID: 3496781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells.
    Tefferi A; Hanson CA; Kurtin PJ; Katzmann JA; Dalton RJ; Nichols WL
    Br J Haematol; 1997 Mar; 96(4):850-3. PubMed ID: 9074430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
    Johnstone IB; Crane S
    Can J Vet Res; 1987 Apr; 51(2):189-93. PubMed ID: 3111674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acquired von Willebrand syndrome: a case series of nine patients and literature review].
    Boissier E; Darnige L; Dougados J; Arlet JB; Dupeux S; Georgin-Lavialle S; Caron C; Tapon-Bretaudière J; Pouchot J; Ranque B
    Rev Med Interne; 2014 Mar; 35(3):154-9. PubMed ID: 23746599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease.
    Dane KE; Lindsley JP; Kickler T; Streiff MB; Moliterno A; Yui J; Naik R; Chaturvedi S
    Blood Adv; 2021 Jul; 5(14):2813-2816. PubMed ID: 34269797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.
    Natorska J; Bykowska K; Hlawaty M; Marek G; Sadowski J; Undas A
    Heart; 2011 Dec; 97(24):2023-8. PubMed ID: 21561895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
    Zimmerman TS; Voss R; Edgington TS
    J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
    Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.
    Meyer D; Obert B; Pietu G; Lavergne JM; Zimmerman TS
    J Lab Clin Med; 1980 Apr; 95(4):590-602. PubMed ID: 6965697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand's disease: a prospective multi-centre study.
    Dunkley S; Baker RI; Pidcock M; Price J; Seldon M; Smith M; Street A; Maher D; Barrese G; Stone C; Lloyd J
    Haemophilia; 2010 Jul; 16(4):615-24. PubMed ID: 20331755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
    Favaloro EJ
    Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.